Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Telescope Innovations Corp (TSE:TELI)
CNQX:TELI
Holding TSE:TELI?
Track your performance easily
TELI Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.16 - C$0.55
Previous CloseC$0.44
Volume4.50K
Average Volume (3M)49.38K
Market Cap
C$22.58M
Enterprise ValueC$24.23M
Total Cash (Recent Filing)C$374.09K
Total Debt (Recent Filing)C$2.02M
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Dec 20, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding53,665,569
10 Day Avg. Volume21,568
30 Day Avg. Volume49,378
Standard Deviation0.21
R-Squared0.13
Alpha-0.00719
Financial Highlights & Ratios
Price to Book (P/B)10.88
Price to Sales (P/S)5.71
Price to Cash Flow (P/CF)-53.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Telescope Innovations Corp News
PremiumCompany Announcements
Telescope Innovations Enhances Lithium Extraction Efficiency
PremiumCompany Announcements
Telescope Innovations Revolutionizes Battery Production
PremiumCompany Announcements
Telescope Innovations Partners with Pfizer to Revolutionize Pharma R&D
PremiumCompany Announcements
Telescope Innovations Advances Sustainable Lithium Tech
PremiumCompany Announcements
Telescope Innovations Reports Soaring Quarterly Revenue
PremiumCompany Announcements
Telescope Innovations Corp. Joins MaRS Hub
PremiumCompany Announcements
Telescope Innovations Unveils Lithium Tech Breakthrough
PremiumCompany Announcements
Telescope Innovations Showcases Cutting-Edge TechOptions Prices
Currently, No data available
---
Ownership Overview
25.06% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
74.94% Public Companies and
Individual Investors
TELI FAQ
What was Telescope Innovations Corp’s price range in the past 12 months?
Telescope Innovations Corp lowest stock price was C$0.15 and its highest was C$0.55 in the past 12 months.
What is Telescope Innovations Corp’s market cap?
Currently, no data Available
When is Telescope Innovations Corp’s upcoming earnings report date?
Telescope Innovations Corp’s upcoming earnings report date is Dec 20, 2024 which is in 90 days.
How were Telescope Innovations Corp’s earnings last quarter?
Telescope Innovations Corp released its earnings results on Jul 11, 2024. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
Is Telescope Innovations Corp overvalued?
According to Wall Street analysts Telescope Innovations Corp’s price is currently Overvalued.
Does Telescope Innovations Corp pay dividends?
Telescope Innovations Corp does not currently pay dividends.
What is Telescope Innovations Corp’s EPS estimate?
Telescope Innovations Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Telescope Innovations Corp have?
Telescope Innovations Corp has 51,919,006 shares outstanding.
What happened to Telescope Innovations Corp’s price movement after its last earnings report?
Telescope Innovations Corp reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Telescope Innovations Corp?
Currently, no hedge funds are holding shares in TSE:TELI
---
Telescope Innovations Corp Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
80.43%
12-Months-Change
Fundamentals
Return on Equity
-40.39%
Trailing 12-Months
Asset Growth
62.75%
Trailing 12-Months
Company Description
Telescope Innovations Corp
Telescope Innovations Corp is a chemical technology company developing synthetic processes to access pharmaceuticals for the treatment of mental health. The company's research and development efforts are focused on medicines from the under-utilized tryptamine class of compounds, leveraging innovative process chemistry to access novel molecules.
---
Technical Analysis
---